In vitro

Global $14+ Billion In-Vitro Toxicology/Toxicity Testing Market by Product & Service, Technology, Method, End-point, End-user & Geography - Forecast to 2025 - ResearchAndMarkets.com

Tuesday, November 12, 2019 - 5:39pm

The global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.

Key Points: 
  • The global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.
  • How is the competitive landscape and who are the market leaders in the global in vitro toxicology testing market?
  • What are the different strategies adopted by the major players in the global in vitro toxicology testing market?
  • Who are the local emerging players in the global in vitro toxicology testing market and how do they compete with the global players?

Opportunities in Global In Vitro Diagnostics Markets, 2019 Report - ResearchAndMarkets.com

Friday, November 8, 2019 - 5:36pm

The "Opportunities in Global In Vitro Diagnostics Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 

The "Opportunities in Global In Vitro Diagnostics Markets" report has been added to ResearchAndMarkets.com's offering.
Coverage in this report includes a detailed analysis of the current and forecast markets for invitro diagnostics technologies.

InSphero joins Science Exchange Network to Offer Expanded Online Access to 3D InSight™ Microtissue Technology and Services

Wednesday, November 6, 2019 - 1:00pm

Under this agreement, InSphero solutions for liver toxicology safety assessments as well as screening platforms for metabolic disease and oncology research, will be available to scientists around the world through Science Exchange.

Key Points: 
  • Under this agreement, InSphero solutions for liver toxicology safety assessments as well as screening platforms for metabolic disease and oncology research, will be available to scientists around the world through Science Exchange.
  • InSphero 3D InSight Discovery and Safety Platforms have been precisely engineered to include the relevant primary human cell types in co-culture required to recapitulate even complex biological mechanisms faithfully in vitro.
  • Since we founded the company in 2009, our goal has been to make our 3D cell technology readily available to researchers around the globe.
  • InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology.

Canadian Metabolomic Technologies Secures $4.2M Series A Financing Round

Monday, October 21, 2019 - 5:00pm

EDMONTON, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Metabolomic Technologies Inc. (MTI), a Canadian-based company developing metabolomics-based in vitro diagnostics today announced the successful completion of a $4.2 million dollar Series A raise.

Key Points: 
  • EDMONTON, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Metabolomic Technologies Inc. (MTI), a Canadian-based company developing metabolomics-based in vitro diagnostics today announced the successful completion of a $4.2 million dollar Series A raise.
  • The Companys lead product, PolypDx, is the world's first and only urine test for colorectal cancer screening.
  • The next critical step to bring MTIs innovative test to patients, is a multi-centre pivotal trial in the United States.
  • Metabolomic Technologies Inc. (MTI) is a small but growing Canadian company developing metabolomic-based in vitro diagnostics.

Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210

Tuesday, October 15, 2019 - 1:30pm

This study is consistent with Therapix's pipeline to develop cannabinoid based therapies.

Key Points: 
  • This study is consistent with Therapix's pipeline to develop cannabinoid based therapies.
  • The study consisted of in vitro tests which examined potential synergy between CBD and PEA.
  • The study was performed in hepatocytes model of fat accumulation, where each compound was tested in a range of concentrations.
  • Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists.

Hungary Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 8:43pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Hong Kong Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:52pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Thailand Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:48pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Mexico Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:43pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

North American Nucleic Acid Testing Analyzers and Reagent Market for 100 Assays: US, Canada, Mexico - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:23pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.
  • Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.